Smoking history not assessed in cancer trials, study finds

June 14, 2012

Cancer trials typically do not assess smoking history of participants even though studies have shown tobacco use has adverse effects on cancer treatments, researchers at Roswell Park Cancer Institute and Yale Cancer Center report in a study published in the Journal of Cancer Oncology.

The study — led by Dr. Graham Warren at Roswell Park and conducted by Yale psychiatry postdoctoral researcher Erica N. Peters — looked at 155 National Cancer Institute-sponsored trials, and showed that only 29% assessed tobacco use.

“It is shocking that most of these trials don’t assess ,” said Dr. Benjamin Toll, Peters’ mentor in psychiatry.

Explore further: Study recommends national standards for tobacco use treatment

More information: jco.ascopubs.org/cgi/doi/10.1200/JCO.2011.40.8815

Related Stories

Study recommends national standards for tobacco use treatment

April 17, 2012
A cancer diagnosis doesn’t automatically get people to stop smoking, but continuing to smoke shortens patients’ survival, increases their risk for a second tumor, and is associated with worse outcomes after cancer ...

Nanoparticles cut off 'addicted' tumors from source of their survival

May 28, 2012
(Medical Xpress) -- Yale biologists and engineers have designed drug-loaded nanoparticles that target the soft underbelly of many types of cancer — a tiny gene product that tumors depend upon to replicate and survive.

Many people continue to smoke after being diagnosed with cancer

January 23, 2012
A new analysis has found that a substantial number of lung and colorectal cancer patients continue to smoke after being diagnosed. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, ...

Barrett's patients who smoke twice as likely to develop oesophageal cancer

January 30, 2012
Smoking doubles the risk of developing oesophageal cancer in people with Barrett's Oesophagus, according to scientists at Queen's University Belfast and the Northern Ireland Cancer Registry.

Cuba releases world's first lung cancer vaccine

September 8, 2011
(Medical Xpress) -- As the most common and deadliest form of cancer, lung cancer kills 1.4 million people per year worldwide, according to the World Health Organization. While current treatments may improve the survival rate ...

Recommended for you

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

Liquid biopsy results differed substantially between two providers

December 14, 2017
Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers. Liquid biopsy is a new and noninvasive alternative ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.